Q1 2023 Holdings
Filed 2023-05-15 | 72 holdings | $242.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Pharvaris NV(PHVS) | EQUITIES | N69605108 | $4.5M | 559,387 | 1.9% |
| Veracyte Inc(VCYT) | EQUITIES | 92337F107 | $4.7M | 209,653 | 1.9% |
| BioCryst Pharmaceuticals Inc(BCRX) | EQUITIES | 09058V103 | $4.8M | 577,757 | 2.0% |
| Gilead Sciences Inc(GILD) | EQUITIES | 375558103 | $5.0M | 60,130 | 2.1% |
| Aclaris Therapeutics, Inc(ACRS)Call | LONG OPTION CALLS | 00461U105 | $5.3M | 651,400 | 2.2% |
| Pliant Therapeutics, Inc(PLRX)Call | LONG OPTION CALLS | 729139105 | $5.3M | 199,600 | 2.2% |
| Schrodinger Inc(SDGR) | EQUITIES | 80810D103 | $5.6M | 212,825 | 2.3% |
| KalVista Pharmaceuticals Inc(KALV) | EQUITIES | 483497103 | $5.7M | 723,544 | 2.3% |
| Karyopharm Therapeutics Inc(KPTIEUR) | EQUITIES | 48576U106 | $6.0M | 1,541,426 | 2.5% |
| Cogent Biosciences Inc(COGT) | EQUITIES | 19240Q201 | $6.3M | 579,264 | 2.6% |
| Viking Therapeutics Inc(VKTX) | EQUITIES | 92686J106 | $6.3M | 380,000 | 2.6% |
| 89bio Inc(ETNBGBP) | EQUITIES | 282559103 | $6.7M | 438,215 | 2.8% |
| Intra-Cellular Therapies Inc(ITCIEUR) | EQUITIES | 46116X101 | $6.8M | 125,035 | 2.8% |
| Bellus Health Inc(BLU) | EQUITIES | 07987C204 | $7.2M | 1,000,000 | 3.0% |
| Nuvalent Inc(NUVL) | EQUITIES | 670703107 | $7.3M | 281,533 | 3.0% |
| Akero Therapeutics Inc(AKRO) | EQUITIES | 00973Y108 | $7.7M | 202,561 | 3.2% |
| Terns Pharmaceuticals Inc(TERN) | EQUITIES | 880881107 | $7.9M | 667,922 | 3.3% |
| Oric Pharmaceuticals Inc(ORIC) | EQUITIES | 68622P109 | $8.2M | 1,435,945 | 3.4% |
| Poseida Therapeutics Inc(PSTXUSD) | EQUITIES | 73730P108 | $8.3M | 2,689,301 | 3.4% |
| Viewray Inc(VRAYQ) | EQUITIES | 92672L107 | $9.7M | 2,793,748 | 4.0% |
| MacroGenics Inc(MGNX) | EQUITIES | 556099109 | $9.8M | 1,361,809 | 4.0% |
| Merus NV | EQUITIES | N5749R100 | $12.3M | 668,784 | 5.1% |